Experimental vaccine may have saved Hamburg scientist from Ebola feverBMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.b1223 (Published 23 March 2009) Cite this as: BMJ 2009;338:b1223
- Annette Tuffs
A scientist from the Bernard Nocht Institute for Tropical Medicine in Hamburg who was quarantined for a week because of a possible infection with the Ebola fever virus has left the isolation ward of Hamburg University Hospital. She has been transferred to a normal ward, because she had no clinical signs of infection, and neither the virus nor any antibodies against the virus were found in her blood.
This positive development may be due to the use of an experimental vaccine given to the scientist that has never previously been used in humans. The vaccine virus was …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial